nach oben

Erschienen in:

01.06.2006

Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer

verfasst von: David Y. Greenblatt, MD, Todd Woltman, MD, Josephine Harter, MD, James Starling, MD, Eberhard Mack, MD, Herbert Chen, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Fine-needle aspiration (FNA) is accurate in diagnosing papillary, medullary, and anaplastic thyroid cancer, as well as lymphoma. Although many surgeons routinely perform FNA before surgery, some question whether FNA influences operative management. Therefore, to determine whether FNA affects surgical management in patients with thyroid cancer, we reviewed our experience.

Methods

A total of 442 consecutive patients underwent thyroid surgery at 1 academic center. Of these, 411 had surgery for an index nodule in the absence of previous radiation or familial thyroid cancer. FNA, operative, and permanent histology findings were reviewed.

Results

The average patient age was 46 years, and 79% were female. A total of 211 patients (51%) had a preoperative FNA, and 71 (17%) had a final diagnosis of cancer. The sensitivity and specificity of FNA for thyroid cancer were 89% and 92%, respectively. In the FNA group, 1 (2.4%) of 41 patients with papillary thyroid cancer required completion thyroidectomy. In contrast, in the no-FNA group, 4 (40%) of 10 patients with papillary thyroid cancer required a second operation. No patient in the FNA group received thyroid resection for lymphoma, whereas three (100%) of three patients with lymphoma in the no-FNA group were treated surgically. A total of 98% of the FNA group, compared with 54% of the no-FNA group, received optimal surgical treatment for thyroid cancer.

Conclusions

FNA is a sensitive and specific test for the diagnosis of thyroid cancer, allowing definitive initial surgery and avoiding unnecessary procedures. Therefore, we recommend routine use of preoperative thyroid FNA, even in those patients in whom a resection is already planned.

Einhorn J, Franzen S. Thin-needle biopsy in the diagnosis of thyroid disease. Acta Radiol 1962; 58:321–36CrossRef

Hamburger JI, Hamburger SW. Declining role of frozen section in surgical planning for thyroid nodules. Surgery 1985; 98:307–12PubMed

Kopald KH, Layfield LJ, Mohrmann R, Foshag LJ, Giuliano AE. Clarifying the role of fine-needle aspiration cytologic evaluation and frozen section examination in the operative management of thyroid cancer. Arch Surg 1989; 124:1201–4; discussion 1204–5PubMed

Paphavasit A, Thompson GB, Hay ID, et al. Follicular and Hurthle cell thyroid neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 1997; 132:674–8; discussion 678–80PubMed

Chen H, Nicol TL, Udelsman R. Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 1995; 222:101–6PubMed

Chen H, Zeiger MA, Clark DP, Westra WH, Udelsman R. Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg 1997; 184:605–10PubMed

Shemen LJ, Chess Q. Fine-needle aspiration biopsy diagnosis of follicular variant of papillary thyroid cancer: therapeutic implications. Otolaryngol Head Neck Surg 1998; 119:600–2CrossRefPubMed

Boyd LA, Earnhardt RC, Dunn JT, Frierson HF, Hanks JB. Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules. J Am Coll Surg 1998; 187:494–502CrossRefPubMed

Sabel MS, Staren ED, Gianakakis LM, Dwarakanathan S, Prinz RA. Use of fine-needle aspiration biopsy and frozen section in the management of the solitary thyroid nodule. Surgery 1997; 122:1021–6; discussion 1026–7CrossRefPubMed

10.

Irish JC, van Nostrand AW, Asa SL, Gullane P, Rotstein L. Accuracy of pathologic diagnosis in thyroid lesions. Arch Otolaryngol Head Neck Surg 1992; 118:918–22PubMed

11.

Layfield LJ, Mohrmann RL, Kopald KH, Giuliano AE. Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer 1991; 68:130–4PubMed

12.

Rodriguez JM, Parrilla P, Sola J, et al. Comparison between preoperative cytology and intraoperative frozen-section biopsy in the diagnosis of thyroid nodules. Br J Surg 1994; 81:1151–4PubMed

13.

Chang HY, Lin JD, Chen JF, et al. Correlation of fine needle aspiration cytology and frozen section biopsies in the diagnosis of thyroid nodules. J Clin Pathol 1997; 50:1005–9PubMed

14.

Brooks AD, Shaha AR, DuMornay W, et al. Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors. Ann Surg Oncol 2001; 8:92–100PubMed

15.

Emerick GT, Duh QY, Siperstein AE, Burrow GN, Clark OH. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 1993; 72:3287–95PubMed

16.

Chen H, Udelsman R. Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin North Am 1998; 7:645–63

17.

Smith RR, Frazell EL, Caulk R, Holinger PH, Russell WO. The American Joint Committee’s proposed method of stage classification and end-result reporting applied to 1,320 pharynx cancers. Cancer 1963; 16:1505–20PubMed

18.

Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 1992; 70:1585–90PubMed

19.

Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001; 11:877–81CrossRefPubMed

20.

Kim ES, Kim TY, Koh JM, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) 2004; 61:145–8CrossRef

21.

Tollefsen HR, Decosse JJ. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 1963; 106:728–34PubMedCrossRef

22.

Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19:545–76PubMed

23.

DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71:414–24PubMedCrossRef

24.

Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714–20CrossRefPubMed

25.

Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418–28CrossRefPubMed

26.

Menegaux F, Turpin G, Dahman M, et al. Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery 1999; 126:479–83PubMed

27.

Reeve TS, Delbridge L, Brady P, Crummer P, Smyth C. Secondary thyroidectomy: a twenty-year experience. World J Surg 1988; 12:449–53CrossRefPubMed

28.

Wilson DB, Staren ED, Prinz RA. Thyroid reoperations: indications and risks. Am Surg 1998; 64:674–8; discussion 678–9PubMed

29.

Chao TC, Jeng LB, Lin JD, Chen MF. Reoperative thyroid surgery. World J Surg 1997; 21:644–7CrossRefPubMed

30.

Compagno J, Oertel JE. Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases. Am J Clin Pathol 1980; 74:1–11PubMed

31.

Doria R, Jekel JF, Cooper DL. Thyroid lymphoma. The case for combined modality therapy. Cancer 1994; 73:200–6PubMed

32.

Tsang RW, Gospodarowicz MK, Sutcliffe SB, Sturgeon JF, Panzarella T, Patterson BJ. Non-Hodgkin’s lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group. Int J Radiat Oncol Biol Phys 1993; 27:599–604PubMed

33.

Staunton MD, Greening WP. Clinical diagnosis of thyroid cancer. Br Med J 1973; 4:532–5PubMedCrossRef

34.

Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin’s lymphoma. Cancer 1997; 80:2311–20CrossRefPubMed

35.

Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312:601–4PubMedCrossRef

36.

Kato I, Tajima K, Suchi T, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985; 76:1085–90PubMed

37.

Pedersen RK, Pedersen NT. Primary non-Hodgkin’s lymphoma of the thyroid gland: a population based study. Histopathology 1996; 28:25–32CrossRefPubMed

38.

Campbell DJ, Sage RH. Thyroid cancer: twenty years’ experience in a general hospital. Br J Surg 1975; 62:207–14PubMed

39.

Hamburger JI, Miller JM, Kini SR. Lymphoma of the thyroid. Ann Intern Med 1983; 99:685–93PubMed

40.

Pasieka JL. Hashimoto’s disease and thyroid lymphoma: role of the surgeon. World J Surg 2000; 24:966–70CrossRefPubMed

41.

Laing RW, Hoskin P, Hudson BV, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 1994; 6:300–4

42.

Skarsgard ED, Connors JM, Robins RE. A current analysis of primary lymphoma of the thyroid. Arch Surg 1991; 126:1199–203; discussion 1203–4PubMed

43.

Pyke CM, Grant CS, Habermann TM, et al. Non-Hodgkin’s lymphoma of the thyroid: is more than biopsy necessary? World J Surg 1992; 16:604–9; discussion 609–10CrossRefPubMed

44.

Aozasa K, Ueda T, Katagiri S, Matsuzuka F, Kuma K, Yonezawa T. Immunologic and immunohistologic analysis of 27 cases with thyroid lymphomas. Cancer 1987; 60:969–73PubMed

45.

Rasbach DA, Mondschein MS, Harris NL, Kaufman DS, Wang CA. Malignant lymphoma of the thyroid gland: a clinical and pathologic study of twenty cases. Surgery 1985; 98:1166–70PubMed

46.

Junor EJ, Paul J, Reed NS. Primary non-Hodgkin’s lymphoma of the thyroid. Eur J Surg Oncol 1992; 18:313–21PubMed

47.

Friedberg MH, Coburn MC, Monchik JM. Role of surgery in stage IE non-Hodgkin’s lymphoma of the thyroid. Surgery 1994; 116:1061–6; discussion 1066–7PubMed

48.

Vigliotti A, Kong JS, Fuller LM, Velasquez WS. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment. Int J Radiat Oncol Biol Phys 1986; 12:1807–12PubMed

49.

Connors JM, Klimo P, Fairey RN, Voss N. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 1987; 107:25–30PubMed

50.

Sasai K, Yamabe H, Haga H, et al. Non-Hodgkin’s lymphoma of the thyroid. A clinical study of twenty-two cases. Acta Oncol 1996; 35:457–62PubMed

51.

Devine RM, Edis AJ, Banks PM. Primary lymphoma of the thyroid: a review of the Mayo Clinic experience through 1978. World J Surg 1981; 5:33–8CrossRefPubMed

52.

Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999; 26:316–23PubMed

53.

Udelsman R, Chen H. The current management of thyroid cancer. Adv Surg 1999; 33:1–27PubMed

54.

Roeher HD, Simon D. Surgical therapy of thyroid cancer. G Chir 1999; 20:5–8PubMed

55.

Klyachkin ML, Schwartz RW, Cibull M, et al. Thyroid lymphoma: is there a role for surgery? Am Surg 1998; 64:234–8PubMed

56.

Cha C, Chen H, Westra WH, Udelsman R. Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? Ann Surg Oncol 2002; 9:298–302CrossRefPubMed

Titel: Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer
verfasst von: David Y. Greenblatt, MD
Todd Woltman, MD
Josephine Harter, MD
James Starling, MD
Eberhard Mack, MD
Herbert Chen, MD
Publikationsdatum: 01.06.2006
Verlag: Springer-Verlag
Erschienen in: Annals of Surgical Oncology / Ausgabe 6/2006
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/ASO.2006.08.020

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer